In non-small cell carcinoma, GA inhibits the activation of the epidermal growth factor receptor (EGFR) and prevents coactivator-associated arginine methyltransferase 1 (CARM1) from binding to proline, glutamate, and leucine-rich protein 1 (PELP1). Here, EGFR is linked to non-small cell lung carcinoma.